Key result
IV methylprednisolone and aspirin linked to symptom resolution in post-COVID-19 MIS-A pericarditis.
Why the study?
Early recognition and treatment of multisystem inflammatory syndrome in adults (MIS-A) with pericarditis after COVID-19 is important but not well established.
Case Report (n=1)
Early recognition and treatment with corticosteroids and aspirin can lead to clinical recovery in patients presenting with MIS-A and pericarditis post-COVID-19.
Answers are grounded in this paper and cite their sources.
Supports potential role for corticosteroids plus aspirin in MIS-A pericarditis; hypothesis-generating and should not yet change practice.
A 24-year-old Vietnamese male patient presented with fever, cough, sore throat, and body pain. Nineteen days previously, the patient experienced nasal discharge and SARS-CoV-2 PCR at local pharmacy was positive. Based on the post COVID-19 status and symptoms, the current diagnosis was multisystem inflammatory syndrome in adults (MIS-A). Treatment with cefazolin was initiated owing to the possibility of bacterial pharyngitis; however, the symptoms did not improve. Additionally, the patient developed pericarditis. Instead of symptomatic therapy, the symptons, in fact, worsened and the patient developed pericarditis. He was then initiated on treatment with a corticosteroid (methylprednisolone 2mg/kg/day by intravenous infusion) and oral aspirin (100mg/day). With this treatment, the patient recovered and was discharged on an oral corticosteroid (prednisolone 30mg/day). We discuss this case along with a review of the literature to underscore the importance of early recognition of MIS-A and the current status of its treatment.
No takes yet. Share an insight, caveat, or question.
MINE et al. (2025) conducted a case report in Multisystem Inflammatory Syndrome in Adults (MIS-A) with Pericarditis (n=1). Corticosteroids (methylprednisolone) and aspirin was evaluated on Clinical recovery. Treatment with intravenous methylprednisolone and oral aspirin successfully resolved symptoms of multisystem inflammatory syndrome in adults (MIS-A) with pericarditis following COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: